DocGo reports Q3 2026 results, lowers revenue outlook and begins CEO succession search
+2 new sources since this summary was written
DocGo Inc. posted third‑quarter 2026 revenue of $73.4 million with a GAAP gross margin of 29.7%. The company cut its full‑year 2026 revenue guidance to roughly $300 million and announced that its board has started a search for a new CEO as current CEO Lee Bienstock’s contract ends on December 31 2026. The pending acquisition of Hicuity Health remains on track for closing in late November or early December.
Why it matters
The lowered revenue outlook contributed to a 6.56% drop in DCGO shares after the earnings release. The CEO transition and acquisition timing add operational uncertainty for investors.
Key facts
- 1Q3 2026 revenue was $73.4 million. tradingview.com
- 2GAAP gross margin was 29.7%. tradingview.com
- 3Adjusted EBITDA was a loss of $3.2 million. tradingview.com
- 4Full‑year 2026 revenue guidance is approximately $300 million. tradingview.com
- 5The board began a CEO search; Lee Bienstock’s contract expires on December 31 2026. tradingview.com
- 6The Hicuity Health acquisition is expected to close in late November or early December. tradingview.com
Open questions
- Net loss is reported as $18.3 million in material 2 but $16.6 million in material 4, both GAAP figures.
- Operating cash flow is shown as a loss of $3.6 million in material 4 and a range of $3 million‑$4 million in material 5.
Summary written by AlphAI AI Desk from 5 of 5 sources. Not investment advice. Figures are as stated by the linked sources.